|
|
|
29.05.26 - 22:06
|
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire EN)
|
|
|
VANCOUVER, British Columbia and BOSTON, MA, May 29, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need, today announced equity inducement grants to 10 new non-officer employees consisting of an aggregate of 32,750 share options and 19,200 restricted share units (RSUs). All of the foregoing share options and RSUs were approved by the Compensation Committee of the Company's Board of Directors with an effective date of May 28, 2026 and were granted as inducements material to the employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4)....
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
29.05.26 - 13:33
|
Glass House Brands Completes Previously Announced Warrant Redemption (GlobeNewswire EN)
|
|
|
LONG BEACH, Calif. and TORONTO, May 29, 2026 (GLOBE NEWSWIRE) -- Glass House Brands Inc. ("Glass House" or the “Company”) (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX: GHBWF) today announced the completion of its previously announced redemption of all remaining warrants (the "Warrants") outstanding under the warrant agency agreement, dated May 13, 2019, between the Company and Odyssey Trust Company, as amended (the "Warrant Agency Agreement")....
|
|
|
|
|
29.05.26 - 13:03
|
Spectral Medical Announces PMA Submission to U.S. FDA for PMX (GlobeNewswire EN)
|
|
|
TORONTO, May 29, 2026 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced the submission of its Premarket Approval (“PMA”) application to the U.S. Food and Drug Administration (“FDA”) for PMX, the Company's endotoxin removal therapy for patients with endotoxic septic shock (“ESS”)....
|
|
|
|
|
29.05.26 - 00:24
|
Buy, hold, sell: Southern Cross Gold, Healius, Centuria Office REIT shares (Fool)
|
|
|
Experts reveal their ratings and 12-month targets on this gold explorer, healthcare provider, and ASX REIT.
The post Buy, hold, sell: Southern Cross Gold, Healius, Centuria Office REIT shares appeared first on The Motley Fool Australia....
|
|
|
|
|
|
|
28.05.26 - 22:42
|
Perimeter Announces First Quarter 2026 Financial Results (PR Newswire)
|
|
|
Conference call/webcast today at 5:00 pm ET TORONTO and DALLAS, May 28, 2026 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, today reported financial results for its first quarter......
|
|
|
|
|
28.05.26 - 22:18
|
Bausch Health′s Aesthetic Business, Solta Medical, Earns Prestigious Trademark Certification of Thermage® in China (PR Newswire)
|
|
|
Thermage®, a pioneer in non-invasive skin tightening, was awarded the AAA Well-Known Trademark Certification, the highest recognition in China's domestic trademark evaluation system. LAVAL, QC, May 28, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global,......
|
|
|
|
|
|
|
28.05.26 - 16:15
|
ProMIS Neurosciences to Participate in Upcoming Conferences in June (GlobeNewswire EN)
|
|
|
CAMBRIDGE, Mass., May 28, 2026 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing antibody therapeutics and vaccines targeting toxic misfolded proteins in neurodegenerative diseases, today announced that it will participate in upcoming June 2026 conferences, and will be available for one-on-one meetings....
|
|